ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Evotec and India's Research Support International Ltd. have formed a joint venture in India, Evotec-RSIL, to design, synthesize, and manage pharmaceutical compound libraries. The joint venture will combine Evotec's expertise in library design, synthesis, analysis, and purification with RSIL's scientists and low-cost structure in India. Evotec says it will move some of its library synthesis equipment from Europe to India. Employment in Europe won't be affected, the company says, as chemists there will focus instead on medicinal chemistry, lead optimization, and development chemistry.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X